D-0656-2025 Class II Ongoing

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0656-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on Sep 4, 2025 and is designated Class II. Reason for recall: Failed Impurity/Degradation Specifications The recall status is ongoing. Affected quantity: 4344 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 24, 2025
Initiation Date
Sep 4, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4344 bottles

Product description

Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reason for recall

Failed Impurity/Degradation Specifications

Distribution pattern

U.S. Nationwide

Code information

Lot E309376; Exp 11/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0656-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0656-2025. Report a data issue: hello@regdatalab.com.